Heron Therapeutics
HRTX
HRTX
193 hedge funds and large institutions have $1.48B invested in Heron Therapeutics in 2021 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 67 increasing their positions, 63 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.36% more ownership
Funds ownership: 99.36% → 99.71% (+0.36%)
22% less capital invested
Capital invested by funds: $1.91B → $1.48B (-$428M)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Holders
193
Holding in Top 10
1
Calls
$19.8M
Puts
$3.99M
Top Buyers
| 1 | +$28M | |
| 2 | +$13.6M | |
| 3 | +$10M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$9.77M |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$8.2M |
Top Sellers
| 1 | -$28.4M | |
| 2 | -$25.2M | |
| 3 | -$18.3M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$17.6M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$9.2M |